OHSU in the news

Schedule Those Doctor's Appointments!

NPR's Science Friday February 24, 2022
Judy Guzman-Cottrill, M.D., says, going forward, seasonal masking could become the norm in certain situations.

Coronavirus in Oregon: Hospitalizations fall below 600

The Oregonian February 23, 2022
The Feb. 17 forecast by Peter Graven, Ph.D., notes COVID-19 hospitalizations are declining faster than expected and predicts that statewide hospitalization cases could fall to 400 by March 20, which could enable the state to repeal its indoor mask requirement sooner.

FDA approves Rinvoq for atopic dermatitis: The details

Medical News Today February 22, 2022
Dr. Eric L. Simpson, MCR, a professor of dermatology and director of clinical research in the Department of Dermatology at Oregon Health & Science University in Portland, explains in a National Eczema Association webinar: “JAK inhibitors all improve itch rapidly within days, the skin rash, and the quality of life. For some of these severe patients, it can be extremely helpful. [However,] if they have a history of blood clots, history of cancer, or a history of severe infection needing hospitalization, I may not use a JAK inhibitor.”

Rinvoq: How does it work?

Medical News Today February 22, 2022
Dr. Eric Simpson, M.C.R., a professor of dermatology and director of clinical research in the Department of Dermatology at Oregon Health & Science University in Portland, outlines the role of cytokines in atopic dermatitis during a National Eczema Association webinar. “Cytokines […] are chemical messengers that your immune system uses […] to tell other cells to coordinate a response to an invader, and, unfortunately, in eczema, your immune system thinks you’re being invaded […] all the time.”

February is American Heart Month

KATU-TV February 22, 2022
Nandita Gupta, M.D., discusses why women are at higher risk for heart disease and how to prevent the condition.
See more stories